Primary prevention with a defibrillator: are therapies always really optimized before implantation?
| Author | |
|---|---|
| Abstract |
:
Left ventricle ejection fraction (LVEF) ≤ 30-35% is widely accepted as a cut-off for primary prevention with an implantable cardiac defibrillator (ICD) in patients with both ischaemic and non-ischaemic cardiomyopathy supposedly on optimal medical therapy. This study reports evolutions of LVEF and treatments of patients implanted in our institution with an ICD for primary prevention of sudden death, after 2 years of follow-up. |
| Year of Publication |
:
2012
|
| Journal |
:
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
|
| Volume |
:
14
|
| Issue |
:
11
|
| Number of Pages |
:
1572-7
|
| ISSN Number |
:
1099-5129
|
| URL |
:
https://academic.oup.com/europace/article-lookup/doi/10.1093/europace/eus187
|
| DOI |
:
10.1093/europace/eus187
|
| Short Title |
:
Europace
|
| Download citation |
